How does autophagy rescue stalled ribosomes?

This project aims to define and characterize a novel autophagy-mediated mechanism for rescuing stalled ER-bound ribosomes, enhancing cellular homeostasis in eukaryotes.

Subsidie
€ 1.999.006
2022

Projectdetails

Introduction

Multiple ribosomes simultaneously move along the mRNAs to translate the genes into proteins. Cellular stress triggers collisions of ribosomes and disrupts protein synthesis. Eukaryotes have evolved multi-tiered quality control mechanisms that monitor ribosomes and rescue them on collision.

Background

While much is known about the rescue of cytosolic ribosomes, how the cell rescues stalled endoplasmic reticulum bound (ER-bound) ribosomes remains unknown. We recently discovered that the stalling of ER-bound ribosomes induces autophagy, a major cellular degradation pathway.

Discoveries

We discovered two autophagy receptors that are induced upon stalling of ER-bound ribosomes, and these proteins are conserved between plants and humans. We also showed that ufmylation, an elusive posttranslational modification system, regulates ER-bound ribosome stalling-induced autophagy.

Hypothesis

These two discoveries indicate that autophagy plays a major role in the maintenance of a functional ER-bound ribosome population. Based on these discoveries, I hypothesize that autophagy rescues stalled ER-bound ribosomes by selectively degrading harmful polypeptides and RNAs that clog the ribosomes during collisions.

Proposed Research

Here, I propose to define and characterize this conserved quality control mechanism. I will establish a suite of complementary methods in the model plants Arabidopsis thaliana and Marchantia polymorpha to explore the physiological significance of autophagy-mediated ribosomal rescue (RiboRescuePhagy) in complex multicellular organisms.

Methodology

In parallel, I will carry out unbiased genetic screens in human cell lines to discover the molecular components that mediate RiboRescuePhagy. Finally, I will perform structure-function analysis of a key ufmylation enzyme to untangle the connection between ufmylation and autophagy.

Conclusion

At the completion of this project, we will have defined a new quality control mechanism that rescues stalled ER-bound ribosomes to maintain cellular homeostasis in eukaryotes.

Financiële details & Tijdlijn

Financiële details

Subsidiebedrag€ 1.999.006
Totale projectbegroting€ 1.999.006

Tijdlijn

Startdatum1-10-2022
Einddatum30-9-2027
Subsidiejaar2022

Partners & Locaties

Projectpartners

  • GREGOR MENDEL INSTITUT FUR MOLEKULARE PFLANZENBIOLOGIE GMBHpenvoerder

Land(en)

Austria

Vergelijkbare projecten binnen European Research Council

ERC Advanced...

Endoplasmic reticulum remodelling via ER-phagy pathways

This project aims to uncover the mechanisms by which ER-phagy receptors regulate endoplasmic reticulum remodelling through ubiquitination and clustering, impacting cellular health and disease.

€ 2.496.691
ERC Starting...

Deciphering co-translational protein folding, assembly and quality control pathways, in health and disease

This project aims to elucidate co-translational protein folding and degradation mechanisms to understand misfolding diseases and improve therapeutic strategies.

€ 1.412.500
ERC Starting...

Mechanisms of human co-translational quality control and it’s role in neural tissue.

This project aims to elucidate the mechanisms of ribosome-associated quality control in humans and its implications for neurodegeneration and aging, using cryo-EM and C. elegans models.

€ 1.500.000
ERC Starting...

Final act of the autophagy symphony: Whole-organism orchestration of autophagy termination

The FINALphagy project aims to develop genetic and computational tools to study and manipulate autophagy termination dynamics in organisms, enhancing understanding of nutrient response mechanisms.

€ 1.500.000
ERC Starting...

Intrinsic autophagy receptors: identity and cellular mechanisms.

This project aims to uncover the role of intrinsic receptors in the selective autophagy of macromolecular complexes, enhancing our understanding of cellular quality control and aging-related diseases.

€ 1.495.000